Related Experiment Video
Updated: Jul 4, 2026
12:16
Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma
Published on: March 13, 2013
Stem cell factor as a novel diagnostic marker for early malignant germ cells
H Stoop1, F Honecker, G J M van de Geijn
1Department of Pathology, Erasmus MC-Erasmus University Medical Center, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Rotterdam, The Netherlands.
The Journal of Pathology
|June 21, 2008
Summary
Early diagnosis of testicular germ cell tumors (TGCTs) is crucial. Stem cell factor (SCF) shows promise as a specific marker for identifying pre-invasive carcinoma in situ (CIS) and gonadoblastoma (GB), especially in cases with germ cell maturation delay.
Area of Science:
- Oncology
- Reproductive Medicine
- Cell Biology
Background:
- Carcinoma in situ (CIS) is the pre-invasive stage of type II testicular germ cell tumors (TGCTs), a common cancer in young males.
- Current diagnostic markers for CIS, like OCT3/4, can lead to overdiagnosis in cases of germ cell maturation delay.
- There is a critical need for more specific markers to differentiate malignant germ cells from those with delayed maturation.
Purpose of the Study:
- To investigate the utility of stem cell factor (SCF) as a diagnostic marker for testicular CIS and gonadoblastoma (GB).
- To evaluate SCF's effectiveness in distinguishing malignant germ cells from germ cells with maturation delay.
- To assess the diagnostic value of SCF immunohistochemistry in various gonadal conditions and TGCT cell lines.
Main Methods:
- Immunohistochemical detection of stem cell factor (SCF) and OCT3/4.
- Analysis of over 400 cases including normal (fetal to adult) and pathological gonads.
- Evaluation of TGCT-derived cell lines.
Main Results:
- Stem cell factor (SCF) expression was detected in both membrane-bound and soluble forms within CIS and GB lesions.
- SCF immunohistochemistry proved informative in distinguishing CIS/GB from germ cells with maturation delay.
- OCT3/4, while informative, showed limitations in cases of germ cell maturation delay, highlighting SCF's added value.
Conclusions:
- Immunohistochemical detection of stem cell factor (SCF) is a valuable tool for diagnosing precursor lesions of TGCTs.
- SCF serves as a specific marker, particularly beneficial in patients with germ cell maturation delay.
- Combining SCF and OCT3/4 immunohistochemistry can enhance the accuracy of screening for TGCT precursor lesions.
